Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://kobipzzb708777.vblogetin.com/44997343/retaglutide-a-promising-glp-1-receptor-agonist